RESUMEN
PURPOSE: We sought to assess the feasibility, reproducibility, and accuracy of conventional and newer echocardiographic measures of right ventricular (RV) systolic function in adolescent and young adult childhood cancer survivors treated with anthracyclines. METHODS: Echocardiography and cardiac magnetic resonance imaging (CMR) were acquired ≤60 days apart in prospectively recruited survivors and RV functional measures were quantitated by blinded observers. Repeat quantitation was performed in a subset to evaluate reproducibility. For each echocardiographic measure, Spearman correlations with CMR measures were calculated, and values in participants with CMR RV ejection fraction (RVEF) ≥48% and RVEF <48% were compared using two sample Wilcoxon rank-sum tests. RESULTS: Among 58 participants, mean age was 18.2 years (range 13.1-25.2) and five participants had CMR RVEF <48%. Intra- and inter-observer coefficients of variation were 8.2%-10.1% and 10.5%-12.0% for adjusted automated strain measures, and 5.2%-8.7% and 2.7% for 3D RVEF, respectively. No echocardiographic measures were significantly correlated with CMR RVEF; only tricuspid annular plane systolic excursion was correlated with CMR RV stroke volume (r = .392, p = .003). Participants with RV dysfunction had worse automated global longitudinal strain (-20.3% vs. -23.9%, p = .007) and free wall longitudinal strain (-23.7% vs. -26.7%, p = .09). CONCLUSIONS: Echocardiographic strain and 3D RV function measurements were feasible and reproducible in at-risk childhood cancer survivors. Although not associated with CMR RVEF in this population with predominantly normal RV function, automated strain measurements were more abnormal in participants with RV dysfunction, suggesting potential clinical utility of these measures.
Asunto(s)
Supervivientes de Cáncer , Ecocardiografía , Estudios de Factibilidad , Insuficiencia Cardíaca , Humanos , Masculino , Femenino , Reproducibilidad de los Resultados , Adolescente , Adulto Joven , Estudios Prospectivos , Adulto , Insuficiencia Cardíaca/fisiopatología , Insuficiencia Cardíaca/complicaciones , Supervivientes de Cáncer/estadística & datos numéricos , Ecocardiografía/métodos , Ventrículos Cardíacos/diagnóstico por imagen , Ventrículos Cardíacos/fisiopatología , Función Ventricular Derecha/fisiología , Sístole , Disfunción Ventricular Derecha/fisiopatología , Disfunción Ventricular Derecha/diagnóstico por imagen , Disfunción Ventricular Derecha/etiología , Neoplasias/complicaciones , Imagen por Resonancia Cinemagnética/métodos , Volumen Sistólico/fisiologíaRESUMEN
This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology focuses on considerations for the comprehensive care of AYA patients with cancer. Compared with older adults with cancer, AYA patients have unique needs regarding treatment, fertility counseling, psychosocial and behavioral issues, and supportive care services. The complete version of the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology addresses additional aspects of caring for AYA patients, including risk factors, screening, diagnosis, and survivorship.
Asunto(s)
Oncología Médica , Neoplasias , Humanos , Adolescente , Adulto Joven , Anciano , Neoplasias/diagnóstico , Neoplasias/terapia , Neoplasias/psicología , Consejo , Supervivencia , Factores de RiesgoRESUMEN
Deregulation of the mTOR pathway may play an important role in tumor biology when the APC/ß-catenin pathway is disrupted in desmoid-type fibromatosis (DT). A pilot study was conducted to determine whether sirolimus can block the mTOR pathway (primary aim) as well as determine whether it can safely be given in the preoperative setting, decrease tumor size/recurrence, and decrease tumor-associated pain in children and young adults (secondary aims) with DT. Nine subjects ages 5-28 years were enrolled from 2014 to 2017 across four centers. Sirolimus was feasible and was associated with a nonstatistically significant decrease in pS706K activation.
RESUMEN
Passive exercise occurs when an individual's limbs are moved via an external force and is a modality that increases cerebral blood flow (CBF) and provides an immediate postexercise executive function (EF) benefit. To our knowledge, no work has examined for how long passive exercise benefits EF. Here, healthy young adults (N = 22; 7 female) used a cycle ergometer to complete three 20-min conditions: passive exercise (via mechanically driven flywheel), a traditional light intensity (37 W) "active" exercise condition (i.e., via volitional pedalling) and a non-exercise control condition. An estimate of CBF was obtained via transcranial Doppler ultrasound measurement of middle cerebral artery blood velocity (MCAv) and antisaccades (i.e., saccade mirror-symmetrical to a target) were completed prior to and immediately, 30- and 60-min following each condition to assess EF. Passive and active exercise increased MCAv; however, the increase was larger in the latter condition. In terms of antisaccades, passive and active exercise provided an immediate postexercise reaction time benefit. At the 30-min assessment, the benefit was observed for active but not passive exercise and neither produced a benefit at the 60-min assessment. Thus, passive exercise provided an evanescent EF "boost" and is a finding that may reflect a smaller cortical hemodynamic response.
Asunto(s)
Función Ejecutiva , Movimientos Sacádicos , Adulto Joven , Humanos , Femenino , Función Ejecutiva/fisiología , Arteria Cerebral Media/diagnóstico por imagen , Circulación Cerebrovascular/fisiología , Tiempo de Reacción/fisiología , Velocidad del Flujo Sanguíneo/fisiologíaRESUMEN
We sought to examine cardiovascular toxicities associated with tyrosine kinase inhibitors in pediatrics. We examined 1624 pediatric adverse events with imatinib, dasatinib, sorafenib, pazopanib, crizotinib, and ruxolitinib reported to the Food and Drug Administration between January 1, 2015, and August 14, 2020. There were 102 cardiovascular event reports. Hypertension was the most commonly reported cardiovascular event and was most frequently associated with sorafenib and pazopanib. The presence of infection increased the reporting odds of cardiovascular events overall and specifically cardiac arrest, heart failure, and hypertension. These data provide early insight into cardiovascular toxicities with tyrosine kinase inhibitor use in pediatrics.
Asunto(s)
Antineoplásicos , Insuficiencia Cardíaca , Hipertensión , Estados Unidos , Humanos , Niño , Sorafenib/efectos adversos , United States Food and Drug Administration , Inhibidores de Proteínas Quinasas/efectos adversos , Insuficiencia Cardíaca/inducido químicamente , Antineoplásicos/efectos adversosRESUMEN
BACKGROUND: Ewing sarcoma is a cancer of bone and soft tissue. Despite aggressive treatment, survival remains poor, particularly in patients with metastatic disease. Failure to treat Ewing sarcoma is due to the lack of understanding of the molecular pathways that regulate metastasis. In addition, no molecular prognostic markers have been identified for Ewing sarcoma to risk stratify patients. PROCEDURE: Ewing sarcoma patients were divided into high or low Twist1 gene expression and survival curves were generated using the R2 microarray-based Genomic Analysis platform (http://r2.amc.nl). Tumors from Ewing sarcoma patients were also evaluated for TWIST1 expression by immunohistochemistry. Ewing sarcoma xenografts were established to evaluate the role of TWIST1 in metastasis. The effects of Twist1 on migration and invasion were evaluated using migration and invasion assays in A673 and RDES cells. RESULTS: Twist1 expression was a negative prognostic marker for overall survival in a public Ewing sarcoma patient data set based on Twist1 mRNA levels and in patient tumor samples based on Twist1 immunohistochemistry. TWIST1 is detected in significantly higher percentage of patients with metastatic diseases than localized disease. Using Ewing sarcoma tumor xenografts in mice, we found that suppressing TWIST1 levels suppressed metastasis without affecting primary tumor development. Knockdown of Twist1 inhibited the migration and invasion capability, while overexpression of Twist1 promoted migration and invasion in Ewing sarcoma cells. CONCLUSION: These results suggest that TWIST1 promotes metastasis in Ewing sarcoma and could be used as a prognostic marker for treatment stratification; however, further validation is required in a larger cohort of patients.